Impact of Estrogen Therapy on Alzheimer's Disease: A Fork in the Road?

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.7, 2004-01, pp. : 405-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is Long-Term Treatment of Alzheimer's Disease with Cholinesterase Inhibitor Therapy Justified?

By Seltzer Ben

Drugs & Aging, Vol. 24, Iss. 11, 2007-01 ,pp. : 881-890

Adis International

Access to resources Recommend Favorite

Selective Inhibitors of Butyrylcholinesterase: A Valid Alternative for Therapy of Alzheimer's Disease?

By Giacobini E.

Drugs & Aging, Vol. 18, Iss. 12, 2001-12 ,pp. : 891-898

Adis International

Access to resources Recommend Favorite

The Economic Impact of Neuropsychiatric Symptoms in Alzheimer’s Disease: Can Drugs Ease the Burden?

By Murman Daniel L.

PharmacoEconomics, Vol. 23, Iss. 3, 2005-01 ,pp. : 227-242

Adis International

Access to resources Recommend Favorite

Is there a Future for Cyclo-Oxygenase Inhibitors in Alzheimer's Disease?

By Ho Lap Qin Weiping Stetka Breton S. Pasinetti Giulio M.

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 85-98

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors in Alzheimer's Disease: Are they Worth the Cost?

By Whitehouse P.J.

CNS Drugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 167-173

Adis International

Access to resources Recommend Favorite